Fundraising Fox

RNAiSSANCE AG

St. Louis, US · Founded 2018 · Delaware LLC · 2 known investors

rnaissanceag.net

RNAiSSANCE AG develops RNAi-based solutions for agricultural pest control, using biomanufacturing, strain development, and entomology research. The company focuses on discovery and production of RNA interference technology for crop protection.

AgTechBiotechClimate Tech

Founders & leadership

BF
Brad FabbriNamed on SEC filing
MH
Michael HelmstetterNamed on SEC filing
BM
Brett MorrisNamed on SEC filing
HW
Harold W. DaviesNamed on SEC filing
SM
Steve MeyerChief Executive Officer

Investors · 2

Reported raises · per SEC filings

Form D private placements

$990K disclosed across 1 round · 2020

$990KraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brad FabbriDirector
  • Michael HelmstetterExecutive Officer, Director
  • Brett MorrisDirector
  • Harold W. DaviesDirector
Offering amount
$990K
Amount sold
$990K
First sale
Jun 2020
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with RNAiSSANCE AG for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does RNAiSSANCE AG do?
RNAiSSANCE AG develops RNAi-based solutions for agricultural pest control, using biomanufacturing, strain development, and entomology research. The company focuses on discovery and production of RNA interference technology for crop protection.
Who are RNAiSSANCE AG's investors?
RNAiSSANCE AG's investors include Missouri Technology Corporation, Cultivation Capital.
How much funding has RNAiSSANCE AG raised?
RNAiSSANCE AG has disclosed $990K raised across 1 round.
Where is RNAiSSANCE AG headquartered?
RNAiSSANCE AG is headquartered in St. Louis, US.